Cargando…

Recombinant Human Parathyroid Hormone Effect on Health-Related Quality of Life in Adults With Chronic Hypoparathyroidism

CONTEXT: Reduced health-related quality of life (HRQoL) is common in patients with hypoparathyroidism treated conventionally with calcium and active vitamin D supplements. OBJECTIVE: To examine the effects of recombinant human parathyroid hormone [rhPTH(1-84)] on HRQoL as measured by the 36-Item Sho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vokes, Tamara J, Mannstadt, Michael, Levine, Michael A, Clarke, Bart L, Lakatos, Peter, Chen, Kristina, Piccolo, Rebecca, Krasner, Alan, Shoback, Dolores M, Bilezikian, John P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2017
Materias:	Clinical Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458961/ https://www.ncbi.nlm.nih.gov/pubmed/29099947 http://dx.doi.org/10.1210/jc.2017-01471

Ejemplares similares

Effects of parathyroid hormone rhPTH(1–84) on phosphate homeostasis and vitamin D metabolism in hypoparathyroidism: REPLACE phase 3 study
por: Clarke, Bart L., et al.
Publicado: (2016)

Safety and Efficacy of 5 Years of Treatment With Recombinant Human Parathyroid Hormone in Adults With Hypoparathyroidism
por: Mannstadt, Michael, et al.
Publicado: (2019)

Long-Term Safety and Efficacy of Recombinant Human Parathyroid Hormone (1-84) in Adults With Chronic Hypoparathyroidism
por: Watts, Nelson B, et al.
Publicado: (2023)

OR30-1 Safety and Efficacy of Recombinant Human Parathyroid Hormone 1-84 for the Treatment of Adults with Chronic Hypoparathyroidism: Six-Year Results of the RACE Study
por: Bilezikian, John, et al.
Publicado: (2019)

The PARADIGHM (physicians advancing disease knowledge in hypoparathyroidism) registry for patients with chronic hypoparathyroidism: study protocol and interim baseline patient characteristics
por: Gittoes, Neil, et al.
Publicado: (2021)

SAT-399 Baseline Characteristics from the Observational PARADIGHM Registry of Patients with Chronic Hypoparathyroidism
por: Clarke, Bart L, et al.
Publicado: (2020)

Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26‐Week Results From the Phase 3 PaTHway Trial
por: Khan, Aliya A, et al.
Publicado: (2022)

A Phase I Randomized Trial of Once‐Daily Versus Twice‐Daily Recombinant Human Parathyroid Hormone (1‐84) for Hypoparathyroidism
por: Ing, Steven W., et al.
Publicado: (2023)

Hypoparathyroidism: Replacement Therapy with Parathyroid Hormone
por: Rejnmark, Lars, et al.
Publicado: (2015)

Therapy of Hypoparathyroidism by Replacement with Parathyroid Hormone
por: Rejnmark, Lars, et al.
Publicado: (2014)

Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation
por: Bi, Ruiye, et al.
Publicado: (2017)

Ten-year use of recombinant parathyroid hormone for the treatment of hypoparathyroidism in a boy with partial Jacobsen syndrome
por: Dayal, Devi, et al.
Publicado: (2020)

Clinical Presentation of Hypoparathyroidism
por: Cipriani, Cristiana, et al.
Publicado: (2021)

Psychometric evaluation of the hypoparathyroidism symptom diary
por: Coles, Theresa, et al.
Publicado: (2019)

Development of a Patient-Reported Outcome Measure for Chronic Hypoparathyroidism
por: Martin, Susan, et al.
Publicado: (2019)

Five-year Estimated Glomerular Filtration Rate in Patients With Hypoparathyroidism Treated With and Without rhPTH(1–84)
por: Chen, Kristina S, et al.
Publicado: (2020)

Etiology and Pathophysiology of Hypoparathyroidism: A Narrative Review
por: Pasieka, Janice L., et al.
Publicado: (2022)

Autosomal Dominant Hypocalcemia (Hypoparathyroidism) Types 1 and 2
por: Roszko, Kelly L., et al.
Publicado: (2016)

Association between Decreased Serum Parathyroid Hormone after Total Thyroidectomy and Persistent Hypoparathyroidism
por: Wang, Jian-Biao, et al.
Publicado: (2015)

Safety and Efficacy of Oral Human Parathyroid Hormone (1‐34) in Hypoparathyroidism: An Open‐Label Study
por: Ish‐Shalom, Sofia, et al.
Publicado: (2021)

Review of Hypoparathyroidism
por: Abate, Ejigayehu G., et al.
Publicado: (2017)

Postoperative Hypoparathyroidism and the Viability of the Parathyroid Glands During Thyroidectomy
por: Ji, Yong Bae, et al.
Publicado: (2017)

Renal complications in patients with chronic hypoparathyroidism on conventional therapy: a systematic literature review: Renal disease in chronic hypoparathyroidism
por: Gosmanova, Elvira O., et al.
Publicado: (2021)

OR23-05 Log-term Efficacy And Safety Of Transcon PTH In Adults With Hypoparathyroidism: 52-week Results From The Open-label Extension Of The Phase 3 Pathway Trial
por: Clarke, Bart, et al.
Publicado: (2023)

Quality of Life in Post-Surgical Hypoparathyroidism (PoSH) in Thyroid and Parathyroid Surgery
por: Hillary, Sarah L., et al.
Publicado: (2022)

Patients’ views about parathyroid transplantation for post-thyroidectomy hypoparathyroidism
por: Stevenson, Alexander, et al.
Publicado: (2018)

OR07-03 Continuous Subcutaneous Delivery of RhPTH(1-84) by Pump in Adults with Hypoparathyroidism
por: Bove-Fenderson, Erin, et al.
Publicado: (2020)

Challenges in the management of chronic hypoparathyroidism
por: Zavatta, Guido, et al.
Publicado: (2020)

Parathyroid Hormone Replacement versus Oral Calcium and Active Vitamin D Supplementation in Hypoparathyroidism: A Meta-analysis
por: Palui, Rajan, et al.
Publicado: (2020)

Relationship between hypoparathyroidism and the number of parathyroid glands preserved during thyroidectomy
por: Song, Chang Myeon, et al.
Publicado: (2014)

Effect of autotransplantation of a parathyroid gland on hypoparathyroidism after total thyroidectomy
por: Su, Anping, et al.
Publicado: (2018)

The Relationship of Magnesium Level with the Recovery of Parathyroid Function in Post-thyroidectomy Hypoparathyroidism
por: Aygun, Nurcihan, et al.
Publicado: (2021)

Simultaneous Kidney and Parathyroid Transplantation in the Management of Genetic Hypoparathyroidism in a Child
por: Vallant, Natalie, et al.
Publicado: (2022)

TransCon PTH as a Hormone Replacement Therapy for Patients with Hypoparathyroidism: 6-Month Update from the PaTH Forward Open-Label Extension
por: Rubin, Mishaela R, et al.
Publicado: (2021)

Measurement of serum intact parathyroid hormone concentration 1 day after total thyroidectomy to assess risk of permanent hypoparathyroidism
por: Zheng, Jianwei, et al.
Publicado: (2020)

Parathyroid hormone of ≥1.6 pmol/L at 6 months is associated with recovery in ‘long-term’ post-surgical hypoparathyroidism
por: Arshad, Muhammad Fahad, et al.
Publicado: (2022)

Kidney Complications and Hospitalization in Patients With Chronic Hypoparathyroidism: A Cohort Study in Sweden
por: Swartling, Oskar, et al.
Publicado: (2022)

Non-Uremic Calciphylaxis: An Unexpected Complication With Recombinant Human Parathyroid Hormone
por: DeClue, Cory, et al.
Publicado: (2021)

IMMUNOCHEMICAL IDENTIFICATION OF PARATHYROID HORMONE IN NON-PARATHYROID NEOPLASMS ASSOCIATED WITH HYPERCALCEMIA
por: Tashjian, Armen H., et al.
Publicado: (1964)

Is it True Hypoparathyroidism? A Root Cause Analysis of Unusually Low Intact Parathyroid Hormone (iPTH) at a Clinical Laboratory
por: Ahmed, Sibtain, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4gecmnb6im3l7n0g7e8elqfd8f